Mol Cell 30(6):689700
GLP-1 medications, with brand names such as Ozempic, Wegovy, and Zepbound, regulate blood sugar in people with type 2 diabetes and are also used for weight loss
DPP-4 inhibitors only modestly affect the levels of endogenous GLP-1, thus producing smaller glycemic reductions with minimal impact on weight reduction
The US list price sits around $1,027 per month per Novo Nordisk, and KFF puts the comparison US figure at $936, versus about $93 in the United Kingdom, $83 in France, $103 in Germany, $147 in Canada, and $169 in Japan for the same brand Ozempic
Dosing, Follow-Up, and Progress Tracking Standard dosing is not the only option
Compounds were administered at the indicated doses at a volume of 5 l g 1